Antaeus Labs is a biopharmaceutical and supplement company dedicated to the discovery, development and commercialization of transdermal delivery systems. Antaeus Labs' mission addresses a simple goal: To develop effective, safe, non-toxic, and pharmacologically inert transdermal delivery systems. The Company commenced operations in 2010 to capitalize on proprietary skin penetration-enhancement technology. Today, the Company is quickly becoming a leader in the discovery and development of novel transdermal delivery systems designed to boost the bioavailability of topically-applied active ingredients to 70%, and perhaps even beyond. Antaeus Labs' first commercial product, TRENAZONE, is a topical/transdermal nordienedione solution, specifically indicated to trigger lean mass increases in healthy male athletes over the age of 21. SOURCE Antaeus Labs